Citation: J. Hoy et Ejm. Wheeler, CHEROKEE OUTLET COWBOY - RECOLLECTIONS OF RECORDS,LABAN,S. - RECORDS,LS, Journal of the West, 37(1), 1998, pp. 118-118
Authors:
CARR A
EMERY S
LLOYD A
HOY J
GARSIA R
FRENCH M
STEWART G
FYFE G
COOPER DA
Citation: A. Carr et al., OUTPATIENT CONTINUOUS INTRAVENOUS INTERLEUKIN-2 OR SUBCUTANEOUS, POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - A RANDOMIZED, CONTROLLED, MULTICENTER STUDY, The Journal of infectious diseases, 178(4), 1998, pp. 992-999
Authors:
LEENDERS ACAP
REISS P
PORTEGIES P
CLEZY K
HOP WCJ
HOY J
BORLEFFS JCC
ALLWORTH T
KAUFFMANN RH
JONES P
KROON FP
VERBRUGH HA
DEMARIE S
Citation: Acap. Leenders et al., LIPOSOMAL AMPHOTERICIN-B (AMBISOME) COMPARED WITH AMPHOTERICIN-B BOTHFOLLOWED BY ORAL FLUCONAZOLE IN THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS, AIDS, 11(12), 1997, pp. 1463-1471
Authors:
DEJONG MD
VELLA S
CARR A
BOUCHER CAB
IMRIE A
FRENCH M
HOY J
SORICE S
PAULUZZI S
CHIODO F
WEVERLING GJ
VANDERENDE ME
FRISSEN PJ
WEIGEL HM
KAUFFMANN RH
LANGE JMA
YOON R
MORONI M
HOENDERDOS E
LEITZ G
COOPER DA
HALL D
REISS P
Citation: Md. Dejong et al., HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION, The Journal of infectious diseases, 175(4), 1997, pp. 966-970
Authors:
NEWELL M
GOLDSTEIN D
MILLIKEN S
LEWIS C
HOY J
THOMSON B
COOPER D
Citation: M. Newell et al., PHASE I II TRIAL OF FILGRASTIM (R-METHUG-CSF), CEOP CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY IN HIV-RELATED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 7(10), 1996, pp. 1029-1036
Citation: M. Pellegrini et al., MYCOPLASMA-PNEUMONIAE INFECTION ASSOCIATED WITH AN ACUTE BRAIN-STEM SYNDROME, Acta neurologica Scandinavica, 93(2-3), 1996, pp. 203-206
Authors:
FERNANDEZCRUZ E
LANG JM
FRISSEN J
FURNER V
CHATEAUVERT M
BOUCHER CAB
DOWD P
STEVENS J
GOLD J
MICHELMORE H
BENSON E
SPELMAN E
HOY J
WRIGHT E
FRENCH M
HUDSON J
MALLAL S
BODSWORTH N
STINGL G
MAYERHOFER S
KRONAWETTER M
TSOUKAS C
SZABO T
KATLAMA C
GUERMONPREZ G
RAFFI F
BILLAUD E
MILPIED B
BOURGEOT V
FLEISHMANN M
BARRIER JH
DELZANT G
WINTER C
MEHARZI J
TREPO C
COTTE L
ROUGIER P
HASSAIRI N
CHOUTET P
BESNIER JM
LAFEUILLADE A
RASOKAT H
GROSS G
MAUSCH HE
STRATIGOS J
POLYDOROV D
STAVRIANEAS N
KIOSSES V
MANDALAKI T
KARAFOULIDOU A
KARABINIS A
STERGIOU G
PLOUMIDES G
PITSAS A
TASSOPOULOS N
KOUTSOUNOPOULOS G
HATZAKIS A
MORONI M
DARMINIO A
BINI T
CHIODO F
COLANGELI V
RICCHI E
AIUTI F
FERRARA R
MEZZAROMA I
LANGE JMA
FRISSEN PHJ
SPRENGER HG
KROON FP
VANDERENDE ME
DEMARIE S
KOOPMANS PP
DOLMANS WMV
SCHREIJ GS
WEIGEL HM
TENNAPEL CHH
TENKATE RW
MARANON G
ZABAY JM
COSIN J
PENA JM
RUBIO R
RIBERA E
VAZQUEZ JMM
LEAL M
ANDREU J
CARTON JA
ASENSI V
GOMEZTRUJILLO F
ORIHUELA F
SERRANO C
FERRER E
MANDAL BK
JOHNSON M
MCKARTHY K
FARMER D
TANG A
MITCHELL SA
BROWN J
TOORAWA R
YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
Citation: Sr. Lewin et al., THE ROLE OF BRONCHOSCOPY IN THE DIAGNOSIS AND TREATMENT OF PULMONARY-DISEASE IN HIV-INFECTED PATIENTS, Australian and New Zealand Journal of Medicine, 25(2), 1995, pp. 133-139
Citation: G. Tachedjian et al., LONG-TERM FOSCARNET THERAPY NOT ASSOCIATED WITH THE DEVELOPMENT OF FOSCARNET-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN AN ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENT, Journal of medical virology, 42(2), 1994, pp. 207-211
Authors:
DIXON PS
FLANIGAN TP
DEBUONO BA
LAURIE JJ
DECIANTIS ML
HOY J
STEIN M
SCOTT HD
CARPENTER CCJ
Citation: Ps. Dixon et al., INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS IN PRISONERS - MEETING THE HEALTH-CARE CHALLENGE, The American journal of medicine, 95(6), 1993, pp. 629-635